The revenue of Amgen Inc. over the past 10 years
Chart Amgen Inc.: revenue, fiscal 2016–2025 Open the chart →Amgen Inc. reported revenue of $36.75B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $22.99B — up 60% over 9 years. Year over year, revenue rose 7 times and fell twice. In these years the lowest $22.85B in fiscal 2017. The largest one-year move was in fiscal 2024: up 19%, from $28.19B to $33.42B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $36.75B |
| 2024ended Dec 31, 2024 | $33.42B |
| 2023ended Dec 31, 2023 | $28.19B |
| 2022ended Dec 31, 2022 | $26.32B |
| 2021ended Dec 31, 2021 | $25.98B |
| 2020ended Dec 31, 2020 | $25.42B |
| 2019ended Dec 31, 2019 | $23.36B |
| 2018ended Dec 31, 2018 | $23.75B |
| 2017ended Dec 31, 2017 | $22.85B |
| 2016ended Dec 31, 2016 | $22.99B |
Fiscal years as Amgen Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Amgen Inc.
- The profitability of Amgen Inc.
- The cash flow of Amgen Inc.
- The debt of Amgen Inc.
- The dividends of Amgen Inc.
- All of Amgen Inc.'s financials, charted
Companies of a similar size
- IBMINTERNATIONAL BUSINESS MACHINES CORPORATION
- LINLinde plc
- TMOTHERMO FISHER SCIENTIFIC INC.
- ARMARM HOLDINGS PLC /UK
- WFCWELLS FARGO & COMPANY/MN
Not investment advice. This page shows what Amgen Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.